cysteine has been researched along with 1-methyl-4-phenylpyridinium in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, FC; Dryhurst, G; Han, J; Yang, Z | 1 |
Ahmad, R; Bandyopadhyay, S; Baptista, MJ; Canet-Avilés, RM; Cookson, MR; McLendon, C; Miller, DW; Petsko, GA; Ringe, D; Wilson, MA | 1 |
Aoyama, K; Matsumura, N; Nakaki, T; Watabe, M | 1 |
Wright, SH; Zhang, X | 1 |
Maldonado, PD; Medina-Campos, ON; Pedraza-Chaverri, J; Rojas, P; Ruiz-Sánchez, E; Serrano-García, N | 1 |
Cheng, Y; Dangprapai, Y; Pelis, RM; Terpstra, J; Wright, SH; Zhang, X | 1 |
6 other study(ies) available for cysteine and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Glutamic Acid; Glutathione; Glycine; Hydrolysis; Hydroxyl Radical; Iron; Kinetics; Male; Microdialysis; Mitochondria; Models, Chemical; Nitro Compounds; Oxygen Consumption; Parkinson Disease; Perfusion; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1999 |
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Substitution; Cell Line, Tumor; Cysteine; Humans; Intracellular Membranes; Intracellular Signaling Peptides and Proteins; Mitochondria; Models, Molecular; Neuroprotective Agents; Neurotransmitter Agents; Oncogene Proteins; Oxidation-Reduction; Oxidative Stress; Protein Deglycase DJ-1; Protein Isoforms; Recombinant Proteins; Static Electricity; Transfection | 2004 |
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra | 2008 |
MATE1 has an external COOH terminus, consistent with a 13-helix topology.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Cell Membrane; Cell Membrane Permeability; CHO Cells; Cricetinae; Cricetulus; Cysteine; Cytosol; Immunohistochemistry; Kinetics; Models, Biological; Models, Molecular; Mutagenesis, Site-Directed; Organic Cation Transport Proteins; Protein Structure, Secondary; Protein Structure, Tertiary; Rabbits; Recombinant Proteins; Structure-Activity Relationship; Transfection | 2009 |
S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Garlic; Glutathione Reductase; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase | 2011 |
Functional significance of conserved cysteines in the human organic cation transporter 2.
Topics: 1-Methyl-4-phenylpyridinium; Alanine; Animals; Biological Transport; Cell Membrane; Cells, Cultured; Cricetinae; Cricetulus; Cysteine; Female; Humans; Mutation; Organic Cation Transport Proteins; Organic Cation Transporter 2; Ovary; Phenylalanine; Tetraethylammonium; Transfection | 2012 |